|
|
Vaccine Detail
|
Personalized follicular lymphoma vaccine |
| Vaccine Information |
- Vaccine Name: Personalized follicular lymphoma vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: Subunit vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: oersonalized peptides (NCT03121677)
- Immunization Route: subcutaneous injection
- Description: The peptides comprising the vaccine are reconstituted in up to 4 pools with 5 peptides per pool (A, B, C, and D). The personalized tumor vaccine will be co-administered with poly-ICLC, nivolumab, and rituximab (or another monoclonal antibody against CD20) to treat Follicular Lymphoma. (NCT03121677)
|
| Host Response |
|
|
| References |
NCT03121677: Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma [https://clinicaltrials.gov/study/NCT03121677]
|
|
